Order Article Reprints

Gerges D, Kapps S, Hernández-Carralero E, Freire R, Aiad M, Schmidt S, Winnicki W, Reiter T, Pajenda S, Schmidt A, et al. Vaccination with BNT162b2 and ChAdOx1 nCoV-19 Induces Cross-Reactive Anti-RBD IgG against SARS-CoV-2 Variants including Omicron. Viruses. 2022; 14(6):1181. https://doi.org/10.3390/v14061181

Gerges, Daniela, Sebastian Kapps, Esperanza Hernández-Carralero, Raimundo Freire, Monika Aiad, Sophie Schmidt, Wolfgang Winnicki, Thomas Reiter, Sahra Pajenda, Alice Schmidt, and et al. 2022. "Vaccination with BNT162b2 and ChAdOx1 nCoV-19 Induces Cross-Reactive Anti-RBD IgG against SARS-CoV-2 Variants including Omicron" Viruses 14, no. 6: 1181. https://doi.org/10.3390/v14061181

Gerges, D., Kapps, S., Hernández-Carralero, E., Freire, R., Aiad, M., Schmidt, S., Winnicki, W., Reiter, T., Pajenda, S., Schmidt, A., Sunder-Plassmann, G., & Wagner, L. (2022). Vaccination with BNT162b2 and ChAdOx1 nCoV-19 Induces Cross-Reactive Anti-RBD IgG against SARS-CoV-2 Variants including Omicron. Viruses, 14(6), 1181. https://doi.org/10.3390/v14061181